AU2661692A - Transgenic mhc class i and class ii antigen-deficient mammals - Google Patents
Transgenic mhc class i and class ii antigen-deficient mammalsInfo
- Publication number
- AU2661692A AU2661692A AU26616/92A AU2661692A AU2661692A AU 2661692 A AU2661692 A AU 2661692A AU 26616/92 A AU26616/92 A AU 26616/92A AU 2661692 A AU2661692 A AU 2661692A AU 2661692 A AU2661692 A AU 2661692A
- Authority
- AU
- Australia
- Prior art keywords
- class
- antigen
- deficient mammals
- mhc class
- transgenic mhc
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 102100036242 HLA class II histocompatibility antigen, DQ alpha 2 chain Human genes 0.000 title 1
- 102000018713 Histocompatibility Antigens Class II Human genes 0.000 title 1
- 108010027412 Histocompatibility Antigens Class II Proteins 0.000 title 1
- 101000930801 Homo sapiens HLA class II histocompatibility antigen, DQ alpha 2 chain Proteins 0.000 title 1
- 241000124008 Mammalia Species 0.000 title 1
- 230000002950 deficient Effects 0.000 title 1
- 230000009261 transgenic effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
- A01K67/027—New or modified breeds of vertebrates
- A01K67/0275—Genetically modified vertebrates, e.g. transgenic
- A01K67/0276—Knock-out vertebrates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
- C07K14/70539—MHC-molecules, e.g. HLA-molecules
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/07—Animals genetically altered by homologous recombination
- A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2227/00—Animals characterised by species
- A01K2227/10—Mammal
- A01K2227/105—Murine
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/03—Animal model, e.g. for test or diseases
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/03—Animal model, e.g. for test or diseases
- A01K2267/035—Animal model for multifactorial diseases
- A01K2267/0381—Animal model for diseases of the hematopoietic system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Environmental Sciences (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Veterinary Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Biodiversity & Conservation Biology (AREA)
- Plant Pathology (AREA)
- Animal Husbandry (AREA)
- Microbiology (AREA)
- Animal Behavior & Ethology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US76282391A | 1991-09-19 | 1991-09-19 | |
| US762823 | 1991-09-19 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2661692A true AU2661692A (en) | 1993-04-27 |
Family
ID=25066106
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU26616/92A Abandoned AU2661692A (en) | 1991-09-19 | 1992-09-21 | Transgenic mhc class i and class ii antigen-deficient mammals |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU2661692A (en) |
| WO (1) | WO1993005817A1 (en) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9100481D0 (en) * | 1991-01-10 | 1991-02-20 | Inst Nat Sante Rech Med | Genetically engineered mice |
| US6664107B1 (en) * | 1993-05-26 | 2003-12-16 | Ontario Cancer Institute, University Health Network | CD45 disrupted nucleic acid |
| CA2161015A1 (en) * | 1993-05-26 | 1994-12-08 | Tak Wah Mak | Transgenic mammals lacking expression of particular cd45 isoforms |
| GB9315303D0 (en) * | 1993-07-23 | 1993-09-08 | Zeneca Ltd | Polypeptide |
| CA2158934A1 (en) * | 1993-09-03 | 1995-03-09 | Jack R. Barber | Methods of suppressing immune response by gene therapy |
| JP2001502883A (en) * | 1996-05-31 | 2001-03-06 | バクスター インターナショナル インコーポレイテッド | Mini adenovirus vector |
| US6403370B1 (en) | 1997-02-10 | 2002-06-11 | Genstar Therapeutics Corporation | Oncolytic/immunogenic complementary-adenoviral vector system |
| WO1998054345A1 (en) * | 1997-05-30 | 1998-12-03 | Baxter International Inc. | Mini-adenoviral vector |
| FR2827302B1 (en) * | 2001-07-13 | 2003-10-10 | Genoway | TRANSGENIC CELL AND ANIMAL MODELING HUMAN ANTIGENIC PRESENTATION AND USES THEREOF |
| EP2699593B2 (en) | 2011-04-20 | 2020-11-04 | University of Washington Through Its Center for Commercialization | Beta-2 microglobulin-deficient cells |
| HRP20171327T1 (en) | 2011-10-28 | 2017-11-03 | Regeneron Pharmaceuticals, Inc. | Genetically modified mice expressing chimeric major histocompatibility complex (mhc) ii molecules |
| PT2770821T (en) | 2011-10-28 | 2017-12-18 | Regeneron Pharma | Genetically modified major histocompatibility complex mice |
| US9591835B2 (en) | 2011-10-28 | 2017-03-14 | Regeneron Pharmaceuticals, Inc. | Genetically modified major histocompatibility complex animals |
| US9043996B2 (en) | 2011-10-28 | 2015-06-02 | Regeneron Pharmaceuticals, Inc. | Genetically modified major histocompatibility complex animals |
| SMT201900429T1 (en) | 2013-02-20 | 2019-09-09 | Regeneron Pharma | Mice expressing humanized t-cell co-receptors |
| US20150342163A1 (en) | 2013-02-22 | 2015-12-03 | Regeneron Pharmaceuticals, Inc. | Genetically modified major histocompatibility complex mice |
| LT2958937T (en) | 2013-02-22 | 2018-11-26 | Regeneron Pharmaceuticals, Inc. | Mice expressing humanized major histocompatibility complex |
| KR102699643B1 (en) | 2015-04-06 | 2024-08-28 | 리제너론 파아마슈티컬스, 인크. | Humanized T cell-mediated immune responses in nonhuman animals |
| BR112023018874A2 (en) | 2021-03-31 | 2023-10-03 | Regeneron Pharma | GENETICALLY MODIFIED MICE COMPRISING COMPONENTS OF THE HUMANIZED CELLULAR IMMUNE SYSTEM WITH IMPROVED DIVERSITY OF THE TCRB REPERTORY |
-
1992
- 1992-09-21 AU AU26616/92A patent/AU2661692A/en not_active Abandoned
- 1992-09-21 WO PCT/US1992/007992 patent/WO1993005817A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO1993005817A1 (en) | 1993-04-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2661692A (en) | Transgenic mhc class i and class ii antigen-deficient mammals | |
| ZA929700B (en) | Piperidinyl and pieraziny alkyl indolones. | |
| AU5182793A (en) | Teleconference system and teleconference module | |
| AU4257193A (en) | Turbo compounder | |
| AU2069992A (en) | Mailbox assembly | |
| AU4303293A (en) | Auditorium | |
| GB2273412B (en) | Film scanner | |
| AU5153093A (en) | Imaging arrangements | |
| AU675433B2 (en) | Benzimidazoles | |
| AU652284B2 (en) | Injectable extended release formulations and methods | |
| AU7453391A (en) | Genetically engineered human lactoferrin | |
| AU4014193A (en) | Chair | |
| AU3679693A (en) | Benzimidazoles | |
| AU5223096A (en) | Insecticidal composition and insecticidal units | |
| AU3464793A (en) | Sitting case | |
| AU3270393A (en) | Flange | |
| AU5112193A (en) | Chair | |
| AU1270592A (en) | Modified interleukin-1beta | |
| AU2013192A (en) | Phi x174 transgenic mammals | |
| AU1578192A (en) | Fungicidal 4-thioxooxazolidin-2-ones and 4-iminooxazolindin-2-ones | |
| AU2279992A (en) | Benzimidazoles | |
| GB9315959D0 (en) | Footrests | |
| AU1883492A (en) | Paper-binder and accessories therefor | |
| AU651895B2 (en) | Ventilators | |
| RU2003840C1 (en) | Fan |